AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Financial Statements
- Click here to download AbbVie, Inc.'s Income Statement
- Click here to download AbbVie, Inc.'s Balance Sheet
- Click here to download AbbVie, Inc.'s Statement of Cash Flows
Key Info
- Industry: Pharmaceuticals: Major
- Sector: Health Technology
- CEO Name: Richard A. Gonzalez
Key Statistics
- Stock Price: $93.95
- Dividend Yield: 4.9%
- Market Capitalization: $165,805,778,500
- Shares Outstanding: 1,764,830,000
- Number of Employees: 30,000
- Trailing 12-Month EPS: $4.71
- Trailing 12-Month DPS: $4.61
- Payout Ratio: 97.89999999999999%
Important Dates
- Next Earnings Date: 2020-10-30
- Next Ex-Dividend Date: 2020-07-14
Price Trends
- Current Stock Price: $93.95
- 52-week high: $101.28
- 52-week low: $62.55
- 200-day moving average: $89
- 50-day moving average: $96.27
Performance
- 1-Month Price Return: -2.1%
- 3-Month Price Return: 3.4%
- 6-Month Price Return: 7.3%
- 1-Year Price Return: 43.7%
- 2-Year Price Return: -0.2%
- 5-Year Price Return: 53.4%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
September 3rd, 2020